Osteoporosis Health Center
This article is from the WebMD News Archive
Dental X-Rays May Warn of Osteoporosis
Jan. 5, 2007 -- Osteoporosisscreening may be helped by dental X-rays, British dental experts report.
They've developed computer software that checks routine dental X-rays for possible warning signs of osteoporosis, in which bones become too thin and are more likely to fracture.
The software developers include Keith Horner, PhD, MSc. He's a professor of oral and maxillofacial surgery at England's University of Manchester.
Horner's team tested the software on 652 women aged 45-70 in Belgium, Greece, Sweden, and the U.K.
The women got bone densityscans of their hip and spine using a special type of X-ray called dual-energy X-ray absorptiometry (DEXA).
The women also got routine dental X-rays that were analyzed with the computer software.
The DEXA scans showed that 140 women had osteoporosis. The computerized dental X-ray analysis didn't flag all of those cases.
But the dental X-ray analysis showed that 119 women were candidates for further bone tests, which later showed that 72 of those women indeed had osteoporosis.
Tapping Useful Information
The dental X-ray software "should not been seen as a replacement" for DEXA, Horner tells WebMD in an email.
Instead, the software may help dentists note patients who might be candidates for further osteoporosis screening, based on their risk factors and medical history.
"The value of our method is that dentists take millions of these X-rays every year for ordinary dental reasons and they contain useful information that isn't being used," Horner says.
"People may be apparently healthy and never visit their family doctor, but often regularly go to their dentist for checkups."
Horner says the analysis could be done without the software, but not as well.
"The software does it automatically and is free from observer errors," Horner says.
The software isn't available yet.
"We are currently negotiating with an industrial partner to get the software out from the laboratory into the dental offices," Horner says.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


